Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Colorcon
Dow
Accenture
Farmers Insurance
UBS
Baxter
Argus Health
Julphar

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204485

« Back to Dashboard

NDA 204485 describes VASOSTRICT, which is a drug marketed by Par Sterile Products and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug. Additional details are available on the VASOSTRICT profile page.

The generic ingredient in VASOSTRICT is vasopressin. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 204485
Tradename:VASOSTRICT
Applicant:Par Sterile Products
Ingredient:vasopressin
Patents:6
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 204485
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VASOSTRICT vasopressin SOLUTION;IV (INFUSION) 204485 NDA Par Pharmaceutical, Inc. 42023-164 N 42023-164-25
VASOSTRICT vasopressin SOLUTION;IV (INFUSION) 204485 NDA Par Pharmaceutical, Inc. 42023-190 N 42023-190-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength20UNITS/ML (20UNITS/ML)
Approval Date:Apr 17, 2014TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jan 30, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES
Patent:➤ Sign UpPatent Expiration:Jan 30, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES
Patent:➤ Sign UpPatent Expiration:Jan 30, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Julphar
Chubb
Healthtrust
UBS
Citi
Moodys
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.